Oral Decitabine/Cedazuridine Is an Effective Ambulatory Therapy for Patients With Myelofibrosis Refractory to JAK2 Inhibitor Therapy

Open Webpage

Shivani Handa, Ganesh Sivakumar, Andrew Srisuwananukorn, Amylou Dueck, Douglas Tremblay, John O Mascarenhas, Yelena Ginzburg, Marina Kremyanskaya, Ronald Hoffman

Published: 01 Sept 2024, Last Modified: 07 Nov 2025Clinical Lymphoma Myeloma and LeukemiaEveryoneRevisionsCC BY-SA 4.0